Norden Gregory

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 37% 68% 82%
Transactions
6 17% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Norden Gregory's trades of Royalty Pharma PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
270.45
Quantity 48,931 +36.6%
Value US$3,460,179
Transaction date
Proposed sale
Price
202.53
Quantity 17,618
Value US$478,367
Transaction date
Proposed sale
Price
196.82
Quantity 39,449
Value US$557,692
Transaction date
Sale
Price
36.23
Quantity 33,500 -14.7%
Value US$1,213,749
US Zoetis Inc (ZTS)
Transaction date
Sale
Price
216.07
Quantity 4,500 -53.6%
Value US$972,315
Transaction date
Sale
Price
38.83
Quantity 10,000 -84.1%
Value US$388,250
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-15 2026-05-14
PlS Planned sale
48,931 +36.6%
270.45
US$3,460,179 		48,931 +36.6% 270.45 US$3,460,179
2026-05-14 2026-05-14
PrS Proposed sale
17,618
202.53
US$478,367 		17,618 202.53 US$478,367
2025-08-11 2025-08-11
PrS Proposed sale
39,449
196.82
US$557,692 		39,449 196.82 US$557,692
2025-08-11 2025-08-11
S Sale
33,500 -14.7%
36.23
US$1,213,749 		33,500 -14.7% 36.23 US$1,213,749
2023-03-08 2023-03-07
B Purchase
12,500 +110.6%
9.84
US$123,000 		12,500 +110.6% 9.84 US$123,000
2021-11-09 2021-11-05
US Zoetis Inc (ZTS)
S Sale
4,500 -53.6%
216.07
US$972,315 		4,500 -53.6% 216.07 US$972,315
2020-12-09 2020-12-07
S Sale
24 -1.3%
58.90
US$1,414 		24 -1.3% 58.90 US$1,414
2020-12-09 2020-12-07
S Sale
10,382 -84.4%
58.32
US$605,478 		10,382 -84.4% 58.32 US$605,478
2020-08-13 2020-08-13
S Sale
10,000 -84.1%
38.83
US$388,250 		10,000 -84.1% 38.83 US$388,250